Malgorzata Kluba, Rudi Van Den Eynde, Oncology, Equities
World Cancer Day 2023
And we would rather not have to go through this – which would mean we won the battle and cancer is curable.
Outlook 2023, Rudi Van Den Eynde
Building a New World: Thematic Investments
In the United States Antonín Dvořák composed the New World Symphony in 1893 and Neil Armstrong took it on a cassette to the moon. Rudi Van den Eynde takes it global, presenting us a New World of long-term trends.
Equities, Rudi Van Den Eynde
Artificial intelligence: a revolution is underway
Artificial intelligence (AI) is about to revolutionise the diagnosis, surveillance and treatment of several diseases. Driven by technological development and research progress, growth in the AI market will surge over the next decade. An explanation.
Equities, Oncology, Rudi Van Den Eynde
Cervical cancer: prevention is better than cure
According to the WHO, vaccinating against the human papillomavirus (HPV) and hepatitis B could prevent 1.1 million cancer cases every year.
Q&A, Health Care, Rudi Van Den Eynde
Biotech investing: is there a doctor in the house?
Rudi Van Den Eynde, Head of Thematic Global Equity at
Candriam, answers investors’ questions about a sector where
depth of specialist knowledge is a prerequisite to consistent
stock selection success.